-

SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Electrocardiogram Biometric Authentication Technology

The University of Aizu collaborated on development of the technology designed to help verify individuals’ identity and protect data integrity

TOKYO--(BUSINESS WIRE)--SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for a system designed to accurately authenticate an individual’s electrocardiogram (ECG) waveform data.

Patent US 11,500,975 B2 describes the system as an authentication device, authentication method, and computer program.

Authentication is essential to protect individuals’ identity, the integrity of sensitive personal data, and the ECG technology that produces the data. Biometrics have shown promise as a next-generation authentication tool because they are difficult to circumvent. ECG signals are especially conducive because they are highly personalized and challenging to counterfeit.

SIMPLEX QUANTUM developed the system with the Public University Corporation of the University of Aizu. “We are pleased to receive US registration for this patent,” says SIMPLEX QUANTUM CEO Ryu Saito. “Breakthrough ECG authentication technology complements our other innovations that advance the use of ECG data to benefit consumers, healthcare professionals, and health systems.”

This patent registration follows US patent registration of artificial intelligence (AI) technology developed by SIMPLEX QUANTUM to determine heart failure stage using ECG data. SIMPLEX QUANTUM technology has not yet received US Food and Drug Administration (FDA) clearance for marketing in the US. However, with its pre-submission application to the FDA, the company has initiated the regulatory pathway to marketing of its technology as a medical device in the US.

About SIMPLEX QUANTUM, Inc.

Founded in 2014, Tokyo-based SIMPLEX QUANTUM develops technology in collaboration with partners including Japan’s Agency for Medical Research and Development. For more information, please visit https://simplex-q.com/en/.

About the University of Aizu

Established in 1993 and located in Fukushima, Japan, the University of Aizu is Japan’s first university specializing in computer science and engineering. It is an international university with approximately 40% of the faculty coming from abroad. For more information, please visit https://u-aizu.ac.jp/en/.

Contacts

Ryu Saito, CEO
telephone: +81 (03) 6450-3600
email: intl_pr@simplex-q.com

SIMPLEX QUANTUM, Inc.


Release Summary
SIMPLEX QUANTUM, Inc. completes US patent registration of Electrocardiogram Biometric Authentication Technology that protects identity and data
Release Versions

Contacts

Ryu Saito, CEO
telephone: +81 (03) 6450-3600
email: intl_pr@simplex-q.com

More News From SIMPLEX QUANTUM, Inc.

SIMPLEX QUANTUM, Inc. Raises Round of Series A Funding

TOKYO--(BUSINESS WIRE)--SIMPLEX QUANTUM, Inc. has raised JPY550 million in a round of Series A funding. Simplex Holdings, Inc., along with the Technology Ventures No. 5 Investment Limited Partnership managed by ITOCHU Technology Ventures (ITV), and ITOCHU Corporation, invested the funds. This investment will help support SIMPLEX QUANTUM’s clinical trial currently underway for submission to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as well as future US Food and Drug Administratio...

SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Artificial Intelligence Technology Designed to Determine Heart Failure Stage Using Electrocardiogram Data

TOKYO--(BUSINESS WIRE)--SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for technology designed to use artificial intelligence (AI) to stage heart failure. Patent US 11,412,978 B2 describes the technology as an information processing system to reduce labor of medical staff in determining heart failure stage. The system references data from hundreds of thousands of electrocardiograms (ECGs) interpreted by clinicians to determine heart failure stage. The SIMPLEX...
Back to Newsroom